Compelling Reasons for Investors to Hold on to MetLife Stock Right Now

31.12.24 18:35 Uhr

Werte in diesem Artikel
Aktien

79,31 EUR -0,34 EUR -0,43%

12,70 EUR 0,20 EUR 1,60%

Indizes

PKT PKT

16.343,6 PKT 27,9 PKT 0,17%

2.918,5 PKT 35,7 PKT 1,24%

5.940,1 PKT 71,6 PKT 1,22%

MetLife, Inc. MET benefits on the back of sound premiums, acquisitions and partnerships, cost-cutting efforts and a solid cash balance.MetLife’s Zacks Rank & Price PerformanceMetLife carries a Zacks Rank #3 (Hold) at present.The stock has gained 23.2% in the past year compared with the industry’s 12.4% growth. Image Source: Zacks Investment Research MET’s Robust Growth ProspectsThe Zacks Consensus Estimate for MetLife’s 2024 earnings is pegged at $8.24 per share, which indicates an improvement of 12.4% from the 2023 reported figure. The consensus mark for revenues is $72.2 billion, implying a rise of 0.7% from the 2023 reported figure. The consensus mark for 2025 earnings is pegged at $9.70 per share, indicating an improvement of 17.7% from the 2024 estimate. The same for revenues is $75.6 billion, indicating a 4.7% increase from the 2024 estimate.MetLife’s Northbound Estimate RevisionThe Zacks Consensus Estimate for 2024 earnings has been revised upward 0.2% in the past seven days.MET’s Solid Return on EquityReturn on equity in the trailing 12 months is currently 20%, which is higher than the industry’s average of 15.3%. This substantiates the company’s efficiency in utilizing shareholders’ funds.MetLife’s Business TailwindsMetLife has seen a steady recovery in its premiums, which are a significant contributor to the revenues of any insurer. In the Group Benefits segment, premiums grew 4.3% year over year in the first nine months of 2024. Additionally, the EMEA and Latin America segments have delivered strong premium growth, further bolstering the company’s revenue base.The company’s emphasis on streamlining operations, strategic acquisitions and collaborations is expected to support sustainable growth. MetLife has expanded its footprint in high-demand areas like vision care and pet insurance through acquisitions of Versant Health and PetFirst, respectively. Partnerships with firms like Aura and Nayya have further enhanced its benefits portfolio.In December 2024, MetLife announced its partnership with Workday, which will integrate the former’s benefits offerings with the latter’s analytics-driven platform. MET has reduced volatility by divesting capital-intensive operations and prioritizing investments in high-growth areas.Cost-saving initiatives have driven significant operational efficiency at MetLife. Between 2015 and 2020, the company improved its direct expense ratio by 230 basis points. This trend has persisted, with the direct expense ratio remaining below the guided 12.3% threshold in the first nine months of 2024.MetLife’s robust liquidity position, evidenced by $21.8 billion in cash and cash equivalents as of Sept. 30, 2024, far exceeds its short-term debt of $404 million. This financial strength supports shareholder returns through share repurchases and dividend payouts. In April 2024, the company increased its dividend by 4.8%, further demonstrating its commitment to rewarding investors. Its dividend yield of 2.7% remains higher than the industry’s average of 2.5%.Stocks to ConsiderSome better-ranked stocks in the insurance space include United Fire Group, Inc. UFCS, Primerica, Inc. PRI and Kinsale Capital Group, Inc. KNSL. United Fire Group sports a Zacks Rank #1 (Strong Buy) at present, and Primerica and Kinsale Capital carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The bottom line of United Fire Group outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 58.79%. The Zacks Consensus Estimate for UFCS’ 2024 earnings is pegged at $1.84 per share. A loss of $1.22 per share was incurred in the prior year. The consensus mark for revenues indicates 13.9% year-over-year growth. The consensus mark for United Fire Group’s 2024 earnings has moved 67.3% north in the past 60 days.Primerica’s earnings outpaced estimates in two of the trailing four quarters and missed the mark twice, the average surprise being 4.89%. The Zacks Consensus Estimate for PRI’s 2024 earnings indicates 20.2% year-over-year growth while the same for revenues implies an improvement of 6.9%. The consensus mark for Primerica’s 2024 earnings has moved 6.7% north in the past 60 days.The bottom line of Kinsale Capital outpaced estimates in each of the trailing four quarters, the average surprise being 9.41%. The Zacks Consensus Estimate for KNSL’s 2024 earnings indicates 24.9% year-over-year growth while the same for revenues implies an improvement of 30.6%. The consensus mark for Kinsale Capital’s 2024 earnings has moved 0.6% north in the past 30 days.Shares of United Fire Group, Primerica and Kinsale Capital have gained 40.9%, 31.8% and 38.5%, respectively, in the past year.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MetLife, Inc. (MET): Free Stock Analysis Report Primerica, Inc. (PRI): Free Stock Analysis Report United Fire Group, Inc (UFCS): Free Stock Analysis Report Kinsale Capital Group, Inc. (KNSL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf MetLife

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MetLife Inc.

Wer­bung

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"